Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?

Mette Vestergaard Elbæk*, Anders Lindholm Sørensen, Hans K Hasselbalch

*Corresponding author for this work
11 Citations (Scopus)

Abstract

In this study, we investigate if chronic inflammation and autoimmunity might be related to the development of chronic myelomonocytic leukemia (CMML). Conducting a case-control study, we included 112 CMML subjects diagnosed at three hematological departments in Denmark between 2003 and 2013. Controls were 231 unmatched chronic lymphatic leukemia (CLL) subjects diagnosed at one of the departments between 2003 and 2012. Subjects with a history of chronic inflammation or autoimmune disorders were retrieved and odds ratios (ORs) calculated. 16.1% of CMML subjects and 6.5% of CLL subjects presented with a history of chronic inflammatory or autoimmune conditions. This was significantly associated with an increased risk of CMML (adjusted OR 3.24, 95% CI: 1.5–7.0). At individual levels, this association was statistically significant for polymyalgia rheumatica and ITP (p values < 0.01 and 0.03, respectively). We found an association of CMML and smoking status (OR 1.42, 95% CI: 1.06–1.90) with more “former smokers” in the CMML group.

Original languageEnglish
JournalLeukemia and Lymphoma
Volume57
Issue number8
Pages (from-to)1793-1799
Number of pages7
ISSN1042-8194
DOIs
Publication statusPublished - 2 Aug 2016

Keywords

  • autoimmune diseases
  • Chronic inflammation
  • chronic myelomonocytic leukemia
  • MDS/MPN
  • smoking

Fingerprint

Dive into the research topics of 'Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?'. Together they form a unique fingerprint.

Cite this